These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2431908)

  • 1. The frequency of hyperamylasemia after ERCP with diatrizoate and iohexol.
    Mäkelä P; Dean PB
    Eur J Radiol; 1986 Nov; 6(4):303-4. PubMed ID: 2431908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.
    Banerjee AK; Grainger SL; Thompson RP
    Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
    Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
    Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate.
    O'Connor HJ; Ellis WR; Manning AP; Lintott DJ; McMahon MJ; Axon AT
    Endoscopy; 1988 Sep; 20(5):244-7. PubMed ID: 3168937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of non-ionic and ionic contrast agents on pancreatic histology in a canine model.
    Pfau PR; Mosley RG; Said A; Gopal DV; Fischer MC; Oberley T; Weiss J; Lee FT; Eckoff D; Reichelderfer M
    JOP; 2006 Jan; 7(1):27-33. PubMed ID: 16407615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ionic, monomer, high osmolar contrast media with non-ionic, dimer, iso-osmolar contrast media in ERCP.
    Ogawa M; Kawaguchi Y; Kawashima Y; Mizukami H; Maruno A; Ito H; Mine T
    Tokai J Exp Clin Med; 2013 Sep; 38(3):109-13. PubMed ID: 24030487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Banerjee A
    Am J Gastroenterol; 1992 May; 87(5):683-4; author reply 684-5. PubMed ID: 1595671
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
    Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
    Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, prospective study comparing two contrast media in ERCP.
    Cunliffe WJ; Cobden I; Lavelle MI; Lendrum R; Tait NP; Venables CW
    Endoscopy; 1987 Sep; 19(5):201-2. PubMed ID: 3678161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of contrast agents for endoscopic retrograde pancreatography.
    Barkin JS; Casal GL; Reiner DK; Goldberg RI; Phillips RS; Kaplan S
    Am J Gastroenterol; 1991 Oct; 86(10):1437-41. PubMed ID: 1928034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis.
    Testoni PA; Mariani A; Masci E; Curioni S
    Dig Liver Dis; 2006 Aug; 38(8):588-95. PubMed ID: 16731060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a rapid urine amylase test using post-ERCP hyperamylasemia as a model.
    Hegewald MJ; Isenberg G; Sterling RK; Cooper GS; Chak A; Sivak MV
    Am J Gastroenterol; 2001 Sep; 96(9):2640-5. PubMed ID: 11569688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of somatostatin on hyperamylasemia following endoscopic pancreatography.
    Tydén G; Nyberg B; Sonnenfeld T; Thulin L
    Acta Chir Scand Suppl; 1986; 530():43-5. PubMed ID: 2425529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis.
    Testoni PA; Bagnolo F; Caporuscio S; Lella F
    Am J Gastroenterol; 1999 May; 94(5):1235-41. PubMed ID: 10235200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of iohexol versus amidotrizoate in endoscopic retrograde pancreatography.
    Jensen AR; Malchow-Møller A; Matzen P; Larsen JE; Møller F; Andersen JR; Magid E
    Scand J Gastroenterol; 1985 Jan; 20(1):83-6. PubMed ID: 2581308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urography with non-ionic contrast media: I. Diagnostic quality and tolerance of iohexol in comparison with meglumine amidotrizoate.
    Taenzer V; Heep H; Clauss W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():148-52. PubMed ID: 6139070
    [No Abstract]   [Full Text] [Related]  

  • 19. Digital subtraction angiography. Comparison of meglumine-Na diatrizoate with iohexol.
    Sackett JF; Bergsjordet B; Seeger JF; Cacayorin ED
    Invest Radiol; 1985; 20(1 Suppl):S58-61. PubMed ID: 2579044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental pancreatography: a comparison of three contrast media.
    Saari A; Kivisaari L; Standertskjöld-Nordenstam CG; Brackett K; Schröder T
    Scand J Gastroenterol; 1988 Jan; 23(1):53-8. PubMed ID: 3344398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.